Adial Pharmaceuticals- Warrants (31/07/2023) Net Tangible Assets

As of the most recent data (June 2026), ADILW shows a net tangible assets of $-38M. That compares with $5.6M in the prior-year period — down 786.4% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ADILW's net tangible assets is now $-38M (was $5.6M) — a 786.4% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Adial Pharmaceuticals- Warrants (31/07/2023) is outperforming or lagging.

Tracking ADILW's net tangible assets over time shows whether Adial Pharmaceuticals- Warrants (31/07/2023) is scaling, shrinking, or reshaping that part of the business. The current reading is $-38M That compares with $5.6M in the prior-year period — down 786.4% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this net tangible assets page, Stockcircle has Adial Pharmaceuticals- Warrants (31/07/2023)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect net tangible assets (currently $-38M) with ownership activity and broader fundamentals.

Adial Pharmaceuticals- Warrants (31/07/2023)'s net tangible assets is $-38M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.